Journal of Hematology & Oncology

official impact factor 2.93
Search for
Advanced search
Journal of Hematology & Oncology
Tools
Share this article
Open Access Highly Access

Mechanism of action of lenalidomide in hematological malignancies

Venumadhav Kotla†, Swati Goel†, Sangeeta Nischal, Christoph Heuck, Kumar Vivek, Bhaskar Das and Amit Verma*

Journal of Hematology & Oncology 2009, 2:36 doi:10.1186/1756-8722-2-36

Accesses  

  • Last 30 days: 419 accesses
  • Last 365 days: 4717 accesses
  • All time: 11448 accesses

Cited by

BioMed Central: 2 citations

Review   Open Access Highly Accessed

Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights

Xiongpeng Zhu, Yuehua Ma, Delong Liu Journal of Hematology & Oncology 2010, 3:17 (23 April 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Letter to the Editor   Open Access

Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: a single center experience from Thailand

Pimjai Niparuck, Ladda Sorakhunpipitkul, Vichai Atichartakarn, Suporn Chuncharunee, Artit Ungkanont, Pantep Aungchaisuksiri, Teeraya Puavilai, Saengsuree Jootar Journal of Hematology & Oncology 2010, 3:1 (5 January 2010)

Abstract | Full text | PDF | PubMed

Google Scholar: View citations

PubMed Central: View citations